Jardiance

CDSCO approves Boehringer Ingelheim’s Jardiance for treating heart failure

Read more

FDA approves Eli Lilly drug to cut death and hospitalisation risk in all heart patients

Read more

Boehringer Ingelheim launches additional heart failure indication for Jardiance in India

Read more

US FDA approves Jardiance to treat adults living with heart failure with reduced ejection fraction

Read more

European Commission approves Jardiance to treat heart failure

Read more

Global diabetes therapeutic market has grown sixfold in last two decades: GlobalData

Read more

SGLT-2 inhibitors may primarily drive growth of branded heart failure treatment market: GlobalData

Read more